Skip to Content
Søg Menu

The ASH Annual Meeting provides several resources on COVID-19 in hematology

A series of studies presented at the ASH 2021 Annual Meeting aim to evaluate the impact of COVID-19 on people with blood cancers and disorders regarding infection, treatments, and vaccination.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Oceanic Influence Suppresses COVID-19 Incidence

/ Karin Ebert / Renate Houts / Sergio Noce
COVID-19

Neutralization titers against SARS-CoV-2 in vaccinated health-care workers

/ Christina Sølund / Alexander James Paul Underwood / Jens Bukh / Nina Weis
VaccinationCOVID-19

Promising Preliminary Efficacy in Patients with Relapsed/Refractory Multiple Myeloma

/ Paul G. Richardson
ASH21Myelomatose Play the Video 7:14
Andrew H. Wei

Maintenance therapy: Oral azacitidine in patients with AML improves long-term overall survival

/ Andrew Wei
ASH21AML Play the Video 8:47

Seks ud af ti medarbejdere fik hudreaktioner ved brug af masker

/ Jette Skiveren / Malene F. Ryborg
AllergiCOVID-19Eksem
Alexander Fosså

CAR-T-terapi til behandling av storcellet B-cellelymfom

/ Alexander Fosså
ASH21Lymfom Play the Video 5:25
Bjørn Tore Gjertsen

Relapse vaccine is a promising treatment for patients with AML

/ Bjørn Tore Gjertsen
ASH21AML Play the Video 5:14
Manali Kamdar

CAR T Cell Therapy – a new standard of care for 2L treatment of R/R in Large B-cell Lymphoma

/ Manali Kamdar
ASH21Lymfom Play the Video 5:52
Matthew S. Davids

ReVenG: Retreatment with venetoclax plus obinutuzumab in patients with relapsed CLL

/ Matthew S. Davids
ASH21CLL Play the Video 2:37

Brænder du for at skrive?

Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk

Send mail til redaktionen
Back to top